Catalyst Wire Dossier Catalyst Wire Dossier

ADX415

· Addrenex Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADX415, covering 2008-12-17 to 2008-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension [Phase 2]

See pricing